Company Overview
JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide. The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, collagen, hygiene and beauty products, metal packaging, biodiesel, and other related businesses. It offers its products under the Seara, Doriana, Pilgrim's, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo, Adaptable Meals, and other brand names. The company was founded in 1953 and is based in Amstelveen, the Netherlands.
Why Investors Should Care
Trades at a P/E of 12.0, below the sector median of 18.6.
Offers a dividend yield of 11.13%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $86.18B (+11.7% YoY); net profit $2.02B.
- Trailing 12 Months Year-on-year growth — revenue +13.8%, earnings -57.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.9%, profit CAGR -12.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.88% |
| 1 Year: | 13.80% |
Compounded Profit Growth
| 5 Years: | -12.26% |
| 1 Year: | -57.20% |
Stock Price Performance
| 1 Year: | -4.46% |
| 6 Months: | -11.00% |
| 3 Months: | +10.76% |
| 1 Month: | -9.56% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)40.44 · Neutral
P/E of 12.03 is below the sector median of 18.56 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 11.13%.
- Generates positive free cash flow.
CONS
- Earnings shrank at -12.3% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JBS JBS N.V. R3K | 12.87 | 12.03 | $9.99B | 11.13% | 12.80% | 13.38% | 5.88% | -12.26% |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 38.82 | $850.02B | 0.93% | 16.83% | 22.31% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 910.18 | 45.88 | $403.65B | 0.65% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.36 | 26.53 | $380.17B | 2.41% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 145.58 | 21.99 | $338.39B | 2.95% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 184.73 | 25.37 | $287.92B | 3.09% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 138.45 | 18.15 | $189.12B | 4.43% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 79.73 | 17.18 | $139.30B | 1.69% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | BTI British American Tobacco p.l.c. | 55.15 | 14.18 | $118.73B | 5.98% | 12.44% | 13.42% | -2.53% | 5.21% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 19.53B | 21.70B | 22.60B | 23.06B | 21.61B |
| Cost of Revenue | 16.90B | 18.78B | 19.62B | 20.19B | 19.28B |
| Gross Profit | 2.62B | 2.93B | 2.97B | 2.87B | 2.32B |
| Operating Expenses | 1.65B | 1.73B | 1.75B | 1.92B | 1.83B |
| Operating Income | 972.28M | 1.19B | 1.22B | 950.62M | 496.79M |
| EBITDA | 1.64B | 1.45B | 2.15B | 1.40B | 1.40B |
| Interest Expense | 414.74M | 391.00M | 480.20M | 404.76M | 469.54M |
| Pretax Income | 694.10M | 761.31M | 815.34M | 374.36M | 308.69M |
| Tax Provision | 137.77M | 146.97M | 171.22M | -60.66M | 67.10M |
| Net Income | 500.22M | 545.87M | 580.89M | 415.14M | 220.59M |
| Diluted EPS | 0.47 | 0.49 | 0.52 | 0.39 | 0.20 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 72.61B | 72.92B | 77.18B | 86.18B |
| Cost of Revenue | - | 61.07B | 64.95B | 65.59B | 74.88B |
| Gross Profit | - | 11.54B | 7.97B | 11.59B | 11.30B |
| Operating Expenses | - | 6.82B | 6.75B | 6.83B | 7.00B |
| Operating Income | - | 4.73B | 1.22B | 4.75B | 4.30B |
| EBITDA | - | 6.80B | 3.62B | 6.55B | 6.61B |
| Interest Expense | - | 1.34B | 1.73B | 1.65B | 1.68B |
| Pretax Income | - | 3.55B | -259.73M | 2.71B | 2.62B |
| Tax Provision | - | 409.96M | -127.99M | 743.39M | 390.51M |
| Net Income | - | 3.00B | -198.87M | 1.77B | 2.02B |
| Diluted EPS | - | 1.34 | -0.19 | 1.65 | 1.89 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 39.89B | 42.58B | 40.69B | 45.16B |
| Current Assets | - | 15.22B | 16.24B | 17.12B | 18.44B |
| Cash & Equivalents | - | 2.53B | 4.57B | 5.61B | 4.57B |
| Inventory | - | 7.25B | 6.81B | 6.62B | 7.93B |
| Receivables | - | 3.88B | 3.39B | 3.74B | 4.23B |
| Total Liabilities | - | 30.34B | 32.87B | 32.55B | 35.63B |
| Current Liabilities | - | 10.57B | 9.90B | 11.66B | 11.54B |
| Long Term Debt | - | 15.69B | 18.93B | 17.24B | 20.26B |
| Total Debt | - | 18.17B | 21.55B | 19.95B | 22.86B |
| Total Equity | - | 8.90B | 9.03B | 7.09B | 8.70B |
| Shares Outstanding | - | 2.22B | 2.22B | 2.22B | 1.16B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.58B | 2.38B | 4.23B | 2.93B |
| Investing Cash Flow | - | -2.54B | -1.41B | -1.42B | -2.31B |
| Financing Cash Flow | - | -1.67B | 1.02B | -1.41B | -1.77B |
| Capital Expenditure | - | -2.18B | -1.51B | -1.49B | -2.11B |
| Free Cash Flow | - | 399.56M | 867.65M | 2.74B | 825.56M |
| Net Change in Cash | - | -1.62B | 1.99B | 1.40B | -1.15B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 15.9% | 10.9% | 15.0% | 13.1% |
| Operating Margin % | - | 6.5% | 1.7% | 6.2% | 5.0% |
| Net Margin % | - | 4.1% | -0.3% | 2.3% | 2.3% |
| ROE % | - | 33.7% | -2.2% | 24.9% | 23.3% |
| ROCE % | - | 16.1% | 3.7% | 16.4% | 12.8% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Bndes Participacoes S.A. | 25.68% | 199.29M | $2.38B |
| 2 | Davis Selected Advisers | 6.44% | 50.02M | $598.19M |
| 3 | Blackrock Inc. | 4.16% | 32.27M | $385.91M |
| 4 | Shaw D.E. & Co., Inc. | 1.45% | 11.28M | $134.86M |
| 5 | State Street Corporation | 1.03% | 8.00M | $95.73M |
| 6 | Brandes Investment Partners L.P. | 0.99% | 7.69M | $92.02M |
| 7 | Ameriprise Financial, Inc. | 0.86% | 6.69M | $80.07M |
| 8 | Arrowstreet Capital, Limited Partnership | 0.78% | 6.02M | $71.96M |
| 9 | Alberta Investment Management Corp | 0.76% | 5.90M | $70.62M |
| 10 | Discovery Capital Management, LLC | 0.70% | 5.44M | $65.02M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for JBS
JBS NV (JBS) (Q2 2026) Earnings Call Highlights: Record Sales and Strategic Expansion Amidst ...
JBS NV (JBS) posts record Q2 net sales of $24 billion, with strategic partnerships and operational improvements offsetting a net loss driven by nonrecurring items.
JBS stock slips as adjusted earnings miss estimates despite record revenue
JBS N. V. (NYSE:JBS) shares edged lower in pre-market trading on Tuesday after the meat producer reported second-quarter adjusted earnings below analyst expectations, even as revenue surpassed forecasts and reached a record level.…
Tomazoni to Become JBS Vice Chairman
Wesley Batista Filho to Become JBS Global CEOAMSTELVEEN, The Netherlands, Aug. 10, 2026 (GLOBE NEWSWIRE) -- JBS N.V. announced today that Wesley Batista Filho will become Global CEO of the Company, effective January 2027. The appointment is…
JBS Forms JV With Indonesian Wealth Fund, Selling 25% Stake in Australia, New Zealand Business for $2.5 Billion
JBS (JBS) will form a joint venture partnership with PT Danantara Investment Management through the
JBS Q2 Earnings Call Highlights
JBS (NYSE:JBS) reported record second-quarter sales of $24 billion as its diversified protein operations helped offset continued pressure in U.S. beef markets, while management outlined a leadership transition and a new Southeast Asia growt…
ETFs to Gain as Trump Waives Off Tariffs on Beef Imports Temporarily
Trump's 90-day beef tariff waiver could lower costs for fast-food chains and meat distributors, benefiting ETFs with exposure to these companies.
JBS — Frequently Asked Questions
What is the current share price of JBS N.V. (JBS)?
As of 2026-09-19 21:16 PDT, JBS N.V. (JBS) trades at $12.87 on NYSE. Its 52-week range is $11.60 to $17.05.
What is the market capitalisation of JBS?
JBS N.V. (JBS) has a market capitalisation of $9.99B on NYSE.
What is the P/E ratio of JBS?
JBS trades at a trailing price-to-earnings (P/E) ratio of 12.03. The industry average P/E is 18.56. Its price-to-book (P/B) ratio is 1.56.
Does JBS pay a dividend?
JBS N.V. (JBS) currently offers a dividend yield of 11.13%.
What is the return on equity (ROE) of JBS?
JBS has a return on equity (ROE) of 13.38%. Its return on capital employed (ROCE) is 12.80%.
Is JBS a good stock to buy?
This page provides a data-driven analysis of JBS N.V. (JBS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.